Guardian Bio
https://www.guardian-bio.comDendritic cell-based platform for cancer therapy
Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.
Total Open and Closed Positions
Total open positions, and positions newly closed since the previous update
Department Headcount Over Time
Open positions per department · top 6 at any point in the window
Newly Opened and Closed Positions
Position Churn Rate
Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels
Time-to-Fill Distribution
Days from open to close · closed positions only
Salary Trend Over Time
Monthly median base salary · USD · annualized · p25/p75 dashed
Salary Range by Department
Employment Type
Technical vs. Non-technical
Open positions · by department
Top Roles by Department
Seniority Mix
Derived from job title keywords
Equity Range by Department
Top Skills
Top Tech Stacks
Skills Trend
Change in share of postings · recent 3 months vs. prior 3 months
Tech Stack Evolution
Positions opened per month · top 5 technologies